PGIM High Yield Bond Fund Inc is a US-based company operating in industry. The company is headquartered in Newark, New Jersey. The company went IPO on 2011-11-14. PGIM High Yield Bond Fund, Inc. (the Fund) is a diversified, closed-end management investment company. The Fund's investment objective is to provide a high level of current income. Under normal market conditions, the Fund will invest at least 80% of its investable assets in a diversified portfolio of high yield fixed income instruments that are rated below investment grade with varying maturities and other investments (including derivatives) with similar economic characteristics. Under normal market conditions, the Fund may invest up to 20% of its investable assets in United States currency denominated and/or foreign currency denominated fixed income instruments issued by foreign issuers. The Fund may invest in issuers who are in default at the time of purchase. The Fund invests in various industries, which include telecommunications, oil and gas, commercial services, home builders, chemicals, entertainment, and others. PGIM Investments LLC serves as the manager of the Fund.
PGIM High Yield Bond Fund Incの収益はセグメントまたは地域別にどのように分けられていますか?
Innovent Biologics Inc の最大収益セグメントは Antibody and Protein Medicine, Pharmaceutical Products and Consultation and Research and Development Services で、最新の利益発表における収益は 10,215,436,051 です。地域別に見ると、China が Innovent Biologics Inc の主要市場であり、収益は 9,740,034,234 です。